Cary J. Claiborne - Mar 25, 2024 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer, Director
Signature
/s/ Cary J. Claiborne
Stock symbol
ADIL
Transactions as of
Mar 25, 2024
Transactions value $
$0
Form type
4
Date filed
3/27/2024, 06:06 PM
Previous filing
Jan 29, 2024
Next filing
Dec 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +60K $0.00 60K Mar 25, 2024 Common Stock 60K $1.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.